IMARC Group, a leading market research company, has recently released a report titled “Cattle Healthcare Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028” The study provides a detailed analysis of the industry, including the cattle healthcare market size, share, trends and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the Cattle Healthcare Market?

The global cattle healthcare market size reached US$ 8.42 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.85 Billion by 2028, exhibiting a growth rate (CAGR) of 4.15% during 2023-2028.

What are Cattle Healthcare?

Cattle healthcare encompasses the comprehensive management of physical and mental well-being of cattle, involving preventative measures, diagnosis, and treatment to maintain their productivity and overall health. The key objectives of this process are disease prevention, optimal nutrition and growth, provision of a clean and safe environment, and effective infection control strategies. Regular monitoring and evaluation of the health of herd are crucial for early detection and treatment of potential issues. It improves animal welfare and productivity and also promotes sustainability in the livestock industry.

Request for a sample copy of this report:

What are the growth prospects and trends in the cattle healthcare industry?

The expanding global population and the inflating disposable income levels of individuals are propelling the demand for animal protein and livestock production, which is primarily driving the cattle healthcare market. Besides this, the growing prevalence of zoonotic diseases, such as bovine tuberculosis, brucellosis, salmonellosis, etc., and the expanding dairy industry, particularly in emerging economies, are further augmenting the market growth. Moreover, continuous technological advancements, the development of innovative cattle healthcare products and services, including vaccines, tests, and medicines, and the rising investments in livestock production by leading manufacturers are also stimulating the market growth. Apart from this, the introduction of sustainable variants and solutions, on account of the increasing consumer environmental concerns, is acting as another significant growth-inducing factor. Furthermore, the launch of several policies by government bodies to promote animal health and welfare, including disease surveillance programs, vaccination campaigns, and regulations to ensure the responsible and ethical use of veterinary drugs, is expected to bolster the cattle healthcare market in the coming years.

What is included in market segmentation?

The report has segmented the market into the following categories:

Product Type Insights:

  • Vaccines
  • Pharmaceuticals
    • Analgesics
    • Anti-infective
    • Anti-inflammatory
    • Parasiticides
    • Others
  • Feed additives
    • Medicinal
    • Nutritional

End User Insights:

  • Dairy farms
  • Veterinary hospitals
  • Others

Buy Full Report:

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Who are the key players operating in the industry?

The report covers the major market players including:

  • BioZyme Inc.
  • Boehringer Ingelheim International GmbH (C.H. Boehringer Sohn AG & Co. KG)
  • Ceva Santé Animale
  • Elanco Animal Health Incorporated
  • Merck & Co. Inc.
  • Virbac
  • Zoetis Inc.

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

Related Reports by IMARC Group :

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US


Email: [email protected]

USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal


See Campaign:

Contact Information:

IMARC Group Email: [email protected] USA: +1-631-791-1145 | Asia: +91-120-433-0800 Address: 134 N 4th St. Brooklyn, NY 11249, USA Follow us on Twitter: @imarcglobal

IPS, Extended Distribution, iCN Internal Distribution, Research Newswire, English